$9.61 Million is the total value of Two Sigma Ventures, LP's 1 reported holdings in Q3 2022. The portfolio turnover from Q2 2022 to Q3 2022 was 50.0% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| RXRX | Sell | RECURSION PHARMACEUTICALS INcl a | $9,612,000 | -34.6% | 903,400 | -50.0% | 100.00% | +12.7% |
| ZY | Exit | ZYMERGEN INC | $0 | – | -1,513,727 | -100.0% | -11.24% | – |
Other managers
Other managers that, in addition to the filing manager(s), that filed the EDGAR filing(s):
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2022-11-14
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| RECURSION PHARMACEUTICALS IN | 4 | Q3 2022 | 100.0% |
| ZYMERGEN INC | 3 | Q2 2022 | 25.3% |
| GITLAB INC | 1 | Q4 2021 | 18.5% |
View Two Sigma Ventures, LP's complete holdings history.
Latest filings
| Type | Filed |
|---|---|
| 13F-HR | 2022-11-14 |
| 13F-HR | 2022-08-15 |
| 13F-HR | 2022-05-16 |
| 13F-HR | 2022-02-14 |
View Two Sigma Ventures, LP's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.